Login to your account

Forgotten password? Click here
Click here to register
Login / Register
You are here:
Home
UK Share Prices
Hemogenyx Pharmaceuticals Share Price
Compared against Kanabo Grp Plc Share Price

Comparing Hemogenyx Pharmaceuticals & Kanabo Grp Plc

This page explains how Hemogenyx Pharmaceuticals compares with Kanabo Grp Plc

In terms of market cap, Hemogenyx Pharmaceuticals is 36.40 times greater than Kanabo Grp Plc, and each share in Hemogenyx Pharmaceuticals is the equivalent to 3,582.22 shares in Kanabo Grp Plc.

  HEMO   KNB
Price 806.00+805.780.225
Change 19.50 (2.48%)+2.480.00 (0%)
Spread 95.00 (12.583%)+12.5830.00 (0.000%)
Currency GBX GBX
Sector Medicine and Biotech Health Care and Related Services
Indices N/A N/A
Hemogenyx Pharmaceuticals Intraday Chart
Kanabo Grp Plc Intraday Chart
Hemogenyx Pharmaceuticals 3 Month Chart
Kanabo Grp Plc 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
HEMO.LN/A N/A N/A N/A N/A
KNB.LN/A N/A N/A N/A N/A
  HEMO   KNB
Shares in Issue 6,425,429   632,427,870
Market Capitalisation £51,788,958   £1,422,963
52 Week High 1,790.00   0.322
52 Week Low 124.50   0.225
Top Risers
Share Change
Mirriad Advertising (MIRI)0.003400%
Sutton Harbour Holdings (SUH)4.2570%
Frontier Ip (FIPP)21.5037.5%
Fiinu (BANK)7.7522.05%
Kazera Global (KZG)1.3514.89%
Top Fallers
Share Change
Atome (ATOM)65.00-25.34%
Firering Strategic Minerals (FRG)1.05-21.57%
Manolete Partn. (MANO)40.50-20%
Light Science Technologies (LST)1.35-16.92%
Huddled Group (HUD)0.95-13.64%
Top By Volume
Share Volume
Mirriad Advertising (MIRI)0.0032,815,567,996
Quantum Helium (QHE)0.031752,268,903,305
Active Energy (AEG)0.12751,048,032,714
Premier African Minerals (PREM)0.0175893,575,171
Tower Resources (TRP)0.0245796,586,392

Copyright © 2026 - Share Compare

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.